Management of Resistant Endometrium in Cases of Recurrent Implantation Failure Using Endometrial Mesenchymal Stem Cells as an Innovative Regenerative Therapy-A Short Communication
Journal Title: Journal of Regenerative Medicine & Biology Research - Year 2020, Vol 1, Issue 1
Abstract
Currently the most accepted definition of Recurrent Implantation Failure (RIF) ,is the absence of achieving clinical pregnancy following transfer of 3 or more good quality embryos in women under 35 years age as well as 4 or in ≥ 35 years age women in fresh or frozen ET’s We had reviewed earlier comprehensively how to manage the endometrial factor in cases of RIF utilizing antibiotics not only orally but further using intrauterine antibiotics and then Platelet Rich Plasma (PRP).Despite that there are certain cases that refuse to respond .We have further delved deeper into pathophysiology of Recurrent Implantation Failure (RIF) along with describing innovatively the use of Mesenchymal Stem Cells (MSCs) cells derived from endometrial stem cells in 29 cases of RIF mixed with PRP that was successful in 23/29 cases besides improving Endometrial Thickness (EMT), but further in Clinical Pregnancy (CP) as well as Live Birth Delivery Rates (LBDR). Further we describe the role of Platelet and Endothelial Cell Adhesion Molecule 1 (PECAM) along with Transforming Growth Factor Beta (TGFβ) besides CDYL in RIF.
Authors and Affiliations
Kulvinder Kochar Kaur*, Gautam Allahbadia, Mandeep Singh
Keywords
Related Articles
- EP ID EP698843
- DOI http://dx.doi.org/10.46889/JRMBR.2020.1104
- Views 73
- Downloads 0
Stem Cell Therapies in Systemic Sclerosis: An Updated Review
Systemic sclerosis systemic is a systemic autoimmune disease that ultimately leads to severe damage and failure of multiple body organs. The disease is associated with significant morbidity and mortality as well as poo...
Management of Resistant Endometrium in Cases of Recurrent Implantation Failure Using Endometrial Mesenchymal Stem Cells as an Innovative Regenerative Therapy-A Short Communication
Currently the most accepted definition of Recurrent Implantation Failure (RIF) ,is the absence of achieving clinical pregnancy following transfer of 3 or more good quality embryos in women under 35 years age as well as...
Numerous Types of Stem Cells Possess Potential to Treat Congenital Hydrocephalus
Twenty-five percent of premature neonate’s experience Intraventricular Hemorrhage (IVH) and 10% of these events are complicated further by the occurrence of hydrocephalus. The number of infants at high risk for IVH and t...
Preparation of Nanofat Concentrate and Its Use for Hypertrophic Scar Treatment
Objective: Nanofat grafting has been reported to improve tissue repair by the Stromal Vascular Fraction (SVF) of nanofat. However, the oil and liquid portions of fat tissues were released by mechanical emulsification dur...
Patient Perspectives on Use of Stem Cells to Treat Osteoporosis
Osteoporosis is a systemic skeletal disease leading to increased risk of fragility fractures. These fractures lead to significant patient morbidity, increased mortality and substantial health and social care costs. Th...